Protocol Ledger

MeSH & Condition-Mapped Clinical Cohorts

Therapeutic Area & Disease Condition Clinical Trial Hubs

Inspect 54,890 interventional Phase II and Phase III ClinicalTrials.gov v2 protocols partitioned deterministically across 10 primary therapeutic condition cohorts, linked to 559 consolidated trial sponsor hubs and 3,600 multi-center study dossiers.

Reconciled Protocols: 54,890 Sponsor Hubs: 559 Indexed NCT Dossiers: 3,600

Cohort ONC · 12,884 Active

Oncology and Hematology

22,601 Phase II and III protocols (3,040 completed, 2,734 stopped early, 1,269-day median span, 43.0 median participants).

3,297 California trials (14.6%) Open cohort

Cohort INF · 1,149 Active

Infectious Disease and Vaccines

5,536 Phase II and III protocols (2,510 completed, 933 stopped early, 456-day median span, 152.0 median participants).

832 California trials (15.0%) Open cohort

Cohort NEU · 1,909 Active

Neurology, Psychiatry, and Pain

4,809 Phase II and III protocols (1,763 completed, 628 stopped early, 714-day median span, 84.0 median participants).

1,121 California trials (23.3%) Open cohort

Cohort CVM · 831 Active

Cardiovascular and Thrombosis

2,184 Phase II and III protocols (799 completed, 245 stopped early, 695-day median span, 102.5 median participants).

403 California trials (18.5%) Open cohort

Cohort RSP · 435 Active

Respiratory and Pulmonary

1,201 Phase II and III protocols (506 completed, 146 stopped early, 651-day median span, 91.0 median participants).

320 California trials (26.6%) Open cohort

Cohort OPH · 295 Active

Ophthalmology and Sensory

936 Phase II and III protocols (438 completed, 95 stopped early, 427-day median span, 106.0 median participants).

317 California trials (33.9%) Open cohort

Ten-Cohort Completion, Attrition, and Enrollment Matrix

ClinicalTrials.gov v2 Phase II and Phase III Benchmarks by Condition Cohort (2018 to 2026)
Code Therapeutic Condition Cohort Protocols Active Completed Stopped Stop % Median N Median Days
ONC Oncology and Hematology 22,601 12,884 3,040 2,734 12.10% 43.0 1,269
OTH Rare Genetic, Women's Health, and Other 10,777 3,944 3,957 1,190 11.04% 60.0 572
INF Infectious Disease and Vaccines 5,536 1,149 2,510 933 16.85% 152.0 456
NEU Neurology, Psychiatry, and Pain 4,809 1,909 1,763 628 13.06% 84.0 714
IMM Immunology, Rheumatology, and Dermatology 3,376 1,326 1,249 466 13.80% 119.0 690
END Endocrinology, Obesity, and Metabolic 2,382 857 1,032 219 9.19% 113.0 616
CVM Cardiovascular and Thrombosis 2,184 831 799 245 11.22% 102.5 695
RSP Respiratory and Pulmonary 1,201 435 506 146 12.16% 91.0 651
GAS Gastroenterology, Hepatology, and Renal 1,088 422 396 140 12.87% 76.0 663
OPH Ophthalmology and Sensory 936 295 438 95 10.15% 106.0 427

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI · Related research: Healthcare Price & Patent Cliff Crosswalk.